Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robbert Hoogeboom
Observed names:
Hoogeboom, Robbert,
R Hoogeboom
Institution:
King's College London
Observed institutions:
King's College London,
The Francis Crick Institute,
Amsterdam UMC Location University of Amsterdam,
Amsterdam University Medical Centers,
National Institute for Medical Research,
University of Amsterdam
show all 6
ORCID:
0000-0002-7256-9285
Observed ORCID:
0000-0002-7256-9285
OpenAlex ID:
A5067700049
Works
19
Awards
3
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi
2013
·
Robbert Hoogeboom
, Kok P.M. van Kessel
, et al.
·
The Journal of Experimental Medicine
·
165
PDF
A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient
2012
·
R Hoogeboom
, T A Wormhoudt
, et al.
·
Leukemia
·
56
Molecular Mechanisms of B Cell Antigen Gathering and Endocytosis
2015
·
Robbert Hoogeboom
, Pavel Tolar
·
Current topics in microbiology and immunology
·
51
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens
2018
·
Oliver Schulz
, Pavel Hanč
, et al.
·
Cell Reports
·
44
PDF
Stereotypic Rheumatoid Factors That Are Frequently Expressed in Mucosa‐Associated Lymphoid Tissue–Type Lymphomas Are Rare in the Labial Salivary Glands of Patients With Sjögren's Syndrome
2014
·
Richard J. Bende
, Linda M. Slot
, et al.
·
Arthritis & Rheumatology
·
42
PDF
Myosin IIa Promotes Antibody Responses by Regulating B Cell Activation, Acquisition of Antigen, and Proliferation
2018
·
Robbert Hoogeboom
, Elizabeth M. Natkanski
, et al.
·
Cell Reports
·
37
PDF
B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains
2016
·
Linda M. Slot
, Robbert Hoogeboom
, et al.
·
American Journal Of Pathology
·
28
PDF
MALT lymphoma–derived rheumatoid factors are nonpolyreactive high-affinity antibodies
2010
·
Robbert Hoogeboom
, Richard J. Bende
, et al.
·
Blood
·
14
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer
2025
·
Bernd B. Zeisig
, Chiou-Tsun Tsai
, et al.
·
Blood
·
10
PDF
In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells
2014
·
R Hoogeboom
, R J A Reinten
, et al.
·
Leukemia
·
10
PDF
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial
2025
·
Jonathan A Cook
, Piers E M Patten
, et al.
·
The Lancet Haematology
·
9
Proliferating CLL cells express high levels of CXCR4 and CD5
2024
·
Daniel Friedman
, Drshika P. Mehtani
, et al.
·
HemaSphere
·
8
PDF
The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial
2023
·
Piers Patten
, Jonathan Cook
, et al.
·
Blood
·
3
Identification of a Novel Proliferating Cell Fraction in Chronic Lymphocytic Leukaemia with High Expression of IgM and Chemokine Receptors
2021
·
Daniel Friedman
, Antony Long
, et al.
·
Blood
·
1
Identification of a Novel B-CLL Subset Expressing Mutated Stereotyped B-Cell Receptors with Specificity for Yeast Mannan
2011
·
Robbert Hoogeboom
, Kok P. van Kessel
, et al.
·
Blood
·
1
Functional Intraclonal Heterogeneity in Chronic Lymphocytic Leukemia: Proliferation vs. Quiescence
2025
·
Daniel Friedman
, Piers E. M. Patten
, et al.
·
Lymphatics
PDF
The impact of pausing Bruton Tyrosine Kinase inhibitor (BTKi) therapy versus continued therapy on vaccination immune response in patients with chronic lymphocytic leukaemia: the IMPROVE RCT
2025
·
Jonathan A Cook
, Piers Patten
, et al.
·
Efficacy and Mechanism Evaluation
We conclude that V1-69/Vk3-20 and V3-7/Vk3-15 MALT lymphoma-derived Igs are ligand-selected, monospecific high- affinity antibodies.
2016
·
Robbert Hoogeboom
, Richard J. Bende
, et al.
The role of antigen in the development of B-cell chronic lymphocytic leukemia
2013
·
Hoogeboom, Robbert
·
UvA-DARE (University of Amsterdam)
PDF
Show more works
View as search
Works count:
19
Citation count:
479
H-index:
10
I10-index:
10
Year
Topic
Type